Partnerships

At Y-mAbs, we are committed to doing the challenging groundwork to develop a strong portfolio of life-changing antibody-based therapies in order to transform outcomes for children and adults battling cancer and other diseases. To that end, Y-mAbs seeks partners who share our dedication and have the capacity to help expand our capabilities through innovation and collaboration.

Global expansion

Y-mAbs seeks partners to expand access to our commercialized products and maximize the global potential of our portfolio.

Business development partners for SADA PRIT targets

Y-mAbs also seeks partners driven to co-develop promising therapies in oncology.

Please contact [email protected] if you are interested in exploring business development opportunities with Y-mAbs.

Partnering with Y-Labs on the SADA PRIT Technology Platform

In addition to exploring additional indications for our commercial product, Y-mAbs is developing antibody-based therapies and diagnostics designed to address some of the most challenging cancers affecting children and young adults, including neuroblastoma and osteosarcoma, as well as adults, including small cell lung cancer, melanoma, and non-Hodgkin’s Lymphoma.

Y-mAbs’ capabilities

Y-mAbs’s talented employees have successfully driven multiple INDs and drug-development campaigns with capabilities to move candidates forward at every stage: drug discovery, toxicology, GMP manufacturing, clinical trial execution, regulatory applications and submissions, product approval and beyond.

From target to “Lead” clinic candidate

Business inquiries

Please email our business development team for any business development inquiries at [email protected].

Mailing address
Y-mAbs Therapeutics, Inc.
Carnegie Center Suite 301
Princeton, NJ, 08540

Phone
+1 646 885 8505